Swine Health Market to Reach $3.3 Billion by 2027
Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 6. - Influencer Pool: 966. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.
New York, March 31, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Swine Health Industry" - https://www.reportlinker.com/p06043709/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.
Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.
Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.
Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.
Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.
Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.
Abstract:
- Global Swine Health Market to Reach $3.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Swine Health estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at aCAGR of 6.8% over the period 2020-2027. Injectables, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oral segment is readjusted to a revised 5.6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $566 Million, While China is Forecast to Grow at 10.4% CAGR
- The Swine Health market in the U.S. is estimated at US$566 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$729 Million by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
- Select Competitors (Total 46 Featured) -
Biogenesis Bago SA
Bio-Vet
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Eco Animal Health Group Plc
Elanco Animal Health
Huvepharma
Indian Immunologicals Ltd.
Lillidale Animal Health
Merck Animal Health
Neogen Corporation
Norbrook Laboratories Limited
Orion Corporation
Phibro Animal Health Corporation
The Arab Pesticides & Veterinary Drugs Mfg. Co. (Mobedco)
Vetoquinol S.A.
Virbac Group
Vitafor NV
Zoetis, Inc.
Read the full report: https://www.reportlinker.com/p06043709/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Swine Health by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 2: World Historic Review for Swine Health by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 3: World 15-Year Perspective for Swine Health by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Injectables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Injectables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Injectables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Oral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 8: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Antibiotics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Antibiotics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for Antibiotics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Vaccines by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Vaccines by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Vaccines by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Other Product
Types by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Other Product Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Other Product Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 19: USA Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 20: USA Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 21: USA 15-Year Perspective for Swine Health by Route Of
Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 22: USA Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 23: USA Historic Review for Swine Health by Product Type -
Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: USA 15-Year Perspective for Swine Health by Product
Type - Percentage Breakdown of Value Sales for Antibiotics,
Vaccines and Other Product Types for the Years 2012, 2020 &
2027
CANADA
Table 25: Canada Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 26: Canada Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 27: Canada 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 28: Canada Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 29: Canada Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: Canada 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
JAPAN
Table 31: Japan Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 32: Japan Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 33: Japan 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 34: Japan Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 35: Japan Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 36: Japan 15-Year Perspective for Swine Health by Product
Type - Percentage Breakdown of Value Sales for Antibiotics,
Vaccines and Other Product Types for the Years 2012, 2020 &
2027
CHINA
Table 37: China Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 38: China Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 39: China 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 40: China Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 41: China Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 42: China 15-Year Perspective for Swine Health by Product
Type - Percentage Breakdown of Value Sales for Antibiotics,
Vaccines and Other Product Types for the Years 2012, 2020 &
2027
EUROPE
Table 43: Europe Current & Future Analysis for Swine Health by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 44: Europe Historic Review for Swine Health by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 45: Europe 15-Year Perspective for Swine Health by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 46: Europe Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 47: Europe Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 48: Europe 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 49: Europe Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 51: Europe 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
FRANCE
Table 52: France Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 53: France Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 54: France 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 55: France Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: France Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 57: France 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
GERMANY
Table 58: Germany Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 59: Germany Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 60: Germany 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 61: Germany Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 62: Germany Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 63: Germany 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
ITALY
Table 64: Italy Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 65: Italy Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 66: Italy 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 67: Italy Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 68: Italy Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 69: Italy 15-Year Perspective for Swine Health by Product
Type - Percentage Breakdown of Value Sales for Antibiotics,
Vaccines and Other Product Types for the Years 2012, 2020 &
2027
UNITED KINGDOM
Table 70: UK Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 71: UK Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 72: UK 15-Year Perspective for Swine Health by Route Of
Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 73: UK Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 74: UK Historic Review for Swine Health by Product Type -
Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 75: UK 15-Year Perspective for Swine Health by Product
Type - Percentage Breakdown of Value Sales for Antibiotics,
Vaccines and Other Product Types for the Years 2012, 2020 &
2027
SPAIN
Table 76: Spain Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 77: Spain Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 78: Spain 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 79: Spain Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 80: Spain Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 81: Spain 15-Year Perspective for Swine Health by Product
Type - Percentage Breakdown of Value Sales for Antibiotics,
Vaccines and Other Product Types for the Years 2012, 2020 &
2027
RUSSIA
Table 82: Russia Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 83: Russia Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 84: Russia 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 85: Russia Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 86: Russia Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 87: Russia 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
REST OF EUROPE
Table 88: Rest of Europe Current & Future Analysis for Swine
Health by Route Of Administration - Injectables and Oral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 89: Rest of Europe Historic Review for Swine Health by
Route Of Administration - Injectables and Oral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 90: Rest of Europe 15-Year Perspective for Swine Health
by Route Of Administration - Percentage Breakdown of Value
Sales for Injectables and Oral for the Years 2012, 2020 & 2027
Table 91: Rest of Europe Current & Future Analysis for Swine
Health by Product Type - Antibiotics, Vaccines and Other
Product Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 92: Rest of Europe Historic Review for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 93: Rest of Europe 15-Year Perspective for Swine Health
by Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
ASIA-PACIFIC
Table 94: Asia-Pacific Current & Future Analysis for Swine
Health by Geographic Region - Australia, India, South Korea and
Rest of Asia-Pacific Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 95: Asia-Pacific Historic Review for Swine Health by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 96: Asia-Pacific 15-Year Perspective for Swine Health by
Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2020 & 2027
Table 97: Asia-Pacific Current & Future Analysis for Swine
Health by Route Of Administration - Injectables and Oral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 98: Asia-Pacific Historic Review for Swine Health by
Route Of Administration - Injectables and Oral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 99: Asia-Pacific 15-Year Perspective for Swine Health by
Route Of Administration - Percentage Breakdown of Value Sales
for Injectables and Oral for the Years 2012, 2020 & 2027
Table 100: Asia-Pacific Current & Future Analysis for Swine
Health by Product Type - Antibiotics, Vaccines and Other
Product Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 101: Asia-Pacific Historic Review for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 102: Asia-Pacific 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
AUSTRALIA
Table 103: Australia Current & Future Analysis for Swine Health
by Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 104: Australia Historic Review for Swine Health by Route
Of Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 105: Australia 15-Year Perspective for Swine Health by
Route Of Administration - Percentage Breakdown of Value Sales
for Injectables and Oral for the Years 2012, 2020 & 2027
Table 106: Australia Current & Future Analysis for Swine Health
by Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 107: Australia Historic Review for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 108: Australia 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
INDIA
Table 109: India Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 110: India Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 111: India 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 112: India Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 113: India Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 114: India 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
SOUTH KOREA
Table 115: South Korea Current & Future Analysis for Swine
Health by Route Of Administration - Injectables and Oral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 116: South Korea Historic Review for Swine Health by
Route Of Administration - Injectables and Oral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 117: South Korea 15-Year Perspective for Swine Health by
Route Of Administration - Percentage Breakdown of Value Sales
for Injectables and Oral for the Years 2012, 2020 & 2027
Table 118: South Korea Current & Future Analysis for Swine
Health by Product Type - Antibiotics, Vaccines and Other
Product Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 119: South Korea Historic Review for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 120: South Korea 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
REST OF ASIA-PACIFIC
Table 121: Rest of Asia-Pacific Current & Future Analysis for
Swine Health by Route Of Administration - Injectables and Oral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 122: Rest of Asia-Pacific Historic Review for Swine
Health by Route Of Administration - Injectables and Oral
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 123: Rest of Asia-Pacific 15-Year Perspective for Swine
Health by Route Of Administration - Percentage Breakdown of
Value Sales for Injectables and Oral for the Years 2012, 2020 &
2027
Table 124: Rest of Asia-Pacific Current & Future Analysis for
Swine Health by Product Type - Antibiotics, Vaccines and Other
Product Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 125: Rest of Asia-Pacific Historic Review for Swine
Health by Product Type - Antibiotics, Vaccines and Other
Product Types Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 126: Rest of Asia-Pacific 15-Year Perspective for Swine
Health by Product Type - Percentage Breakdown of Value Sales
for Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
LATIN AMERICA
Table 127: Latin America Current & Future Analysis for Swine
Health by Geographic Region - Argentina, Brazil, Mexico and
Rest of Latin America Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 128: Latin America Historic Review for Swine Health by
Geographic Region - Argentina, Brazil, Mexico and Rest of Latin
America Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 129: Latin America 15-Year Perspective for Swine Health
by Geographic Region - Percentage Breakdown of Value Sales for
Argentina, Brazil, Mexico and Rest of Latin America Markets for
Years 2012, 2020 & 2027
Table 130: Latin America Current & Future Analysis for Swine
Health by Route Of Administration - Injectables and Oral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 131: Latin America Historic Review for Swine Health by
Route Of Administration - Injectables and Oral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 132: Latin America 15-Year Perspective for Swine Health
by Route Of Administration - Percentage Breakdown of Value
Sales for Injectables and Oral for the Years 2012, 2020 & 2027
Table 133: Latin America Current & Future Analysis for Swine
Health by Product Type - Antibiotics, Vaccines and Other
Product Types - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 134: Latin America Historic Review for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 135: Latin America 15-Year Perspective for Swine Health
by Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
ARGENTINA
Table 136: Argentina Current & Future Analysis for Swine Health
by Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 137: Argentina Historic Review for Swine Health by Route
Of Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 138: Argentina 15-Year Perspective for Swine Health by
Route Of Administration - Percentage Breakdown of Value Sales
for Injectables and Oral for the Years 2012, 2020 & 2027
Table 139: Argentina Current & Future Analysis for Swine Health
by Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 140: Argentina Historic Review for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 141: Argentina 15-Year Perspective for Swine Health by
Product Type - Percentage Breakdown of Value Sales for
Antibiotics, Vaccines and Other Product Types for the Years
2012, 2020 & 2027
BRAZIL
Table 142: Brazil Current & Future Analysis for Swine Health by
Route Of Administration - Injectables and Oral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 143: Brazil Historic Review for Swine Health by Route Of
Administration - Injectables and Oral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 144: Brazil 15-Year Perspective for Swine Health by Route
Of Administration - Percentage Breakdown of Value Sales for
Injectables and Oral for the Years 2012, 2020 & 2027
Table 145: Brazil Current & Future Analysis for Swine Health by
Product Type - Antibiotics, Vaccines and Other Product Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 146: Brazil Historic Review for Swine Health by Product
Type - Antibiotics, Vaccines and Other Product Types Markets -
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06043709/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001